Veeva Rides AI Wave As Pharma Cloud Story Accelerates

Veeva Systems reports Q1 beat and raises guidance. Analysts maintain Buy ratings and see potential in AI initiatives. Latest Ratings for VEEV Date Firm Action From To Mar 2022 JMP Securities Maintains Market Outperform Mar 2022 SVB Leerink Maintains Outperform Mar 2022 B of A Securities Downgrades Buy Neutral View More Analyst Ratings for VEEV View the Latest Analyst Ratings Importance Rank: 1 read more

Go to News Site